Double-Blind, Placebo-Controlled Trial of Topiramate as Add-On Therapy in Patients with Refractory Partial Seizures

スポンサーリンク

概要

• 論文の詳細を見る
• 1996-06-01

著者

• Karim Rezaul

  R. W. Johnson Pharmaceutical Research Institute

• Ben-menachem Elinor

  Sahlgren University Hospital

• Pledger Gordon

  R. W. Johnson Pharmaceutical Research Institute

• SCHMIDT Dieter

  Epilepsy Research Group

• HENRIKSEN Olaf

  National Center for Epilepsy

• DAM Mogens

  Hvidovre Hospital

• MIKKELSEN Marianne

  Hvidovre Hospital

• REID Sybiella

  Epilepsy Research Group

• REIFE Ross

  R. W. Johnson Pharmaceutical Research Institute

• KRAMER Lynn

  R. W. Johnson Pharmaceutical Research Institute

関連論文

• Seizure Recurrence after Planned Discontinuation of Antiepileptic Drugs in Seizure-free Patients after Epilepsy Surgery : A Review of Current Clinical Experience
• Double-Blind, Placebo-Controlled Trial of Topiramate as Add-On Therapy in Patients with Refractory Partial Seizures
• Drug Resistance in Epilepsy : Putative Neurobiologic and Clinical Mechanisms
• Experimental and Clinical Evidence for Loss of Effect (Tolerance) during Prolonged Treatment with Antiepileptic Drugs
• THe Value of the Number-Needed-to-Treat Method in Antiepileptic Drug Trials

スポンサーリンク